Susquehanna initiates coverage on OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) with a Positive rating. Price target $50.

Susquehanna analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE